"Fungal acne" is a misnomer for Malassezia (Pityrosporum) folliculitis, where overgrown Malassezia yeast infects hair follicles and causes an itchy acne-like rash, as Cleveland Clinic describes. Antifungals, not acne antibiotics, clear it, but recurrence is common and lasting cases need medical evaluation. It favors the face, scalp and upper body. It looks like acne at a glance, but its bumps, triggers and treatment differ in practical ways.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How does it differ from acne?
- Who is at risk?
- Why does the mix-up matter?
- How do clinicians confirm it?
- What treatment works, and what if it returns?
How does it differ from acne?
DermNet NZ describes typical lesions as small, uniform, itchy papules and pustules on the upper chest and back, as detailed in the DermNet NZ overview. They lack the blackheads, whiteheads and varied lesion sizes seen in acne vulgaris. That difference helps in daily checks:.
- uniform small red bumps and small pus bumps, often itchy
- little variation in size, with no blackheads or whiteheads
- clusters on upper chest, back and sometimes forehead
Who is at risk?
NCBI StatPearls notes typical patients are adolescents and young adults with oily skin. Yeast thrives where skin stays warm, oily and covered.
Heat, humidity, sweating and occlusive skin products raise risk. Broad-spectrum antibiotics, corticosteroids, diabetes and immunosuppression also increase risk.
Why does the mix-up matter?
Mistaking yeast folliculitis for acne changes care. Dermatology Times, reporting a Journal of the American Academy of Dermatology review, warns that standard acne antibiotics do not help and can worsen Malassezia folliculitis, as explained in this treatment review.
The wrong course delays effective care. That delay can prolong itch and spread on the trunk. It can also expose skin to drugs with no benefit for yeast.
How do clinicians confirm it?
Danish evidence-based guidelines describe confirmation by skin scraping with KOH or direct microscopy showing budding yeast, summarized in the Danish folliculitis guidelines. Sometimes biopsy shows spores packed in follicles.
Routine Malassezia culture has little clinical value. Visual judgment alone is not enough when breakouts resist acne care.
What treatment works, and what if it returns?
Infectious Disease Advisor lists antifungal therapy, not anti-acne therapy, for mild to extensive disease, per this clinical treatment summary. Mild disease uses topical ketoconazole, selenium sulfide or azoles.
Extensive or resistant cases use oral fluconazole 100–200 mg per day or itraconazole 100–200 mg per day for 1–4 weeks. Response is often good, but recurrence is common and evidence is limited, so some patients need maintenance therapy and clinician follow-up rather than a one-time cure. People with itchy, uniform, treatment-resistant "acne" on the chest, back or forehead should seek dermatologic evaluation instead of prolonging acne antibiotics or self-starting oral antifungals.